Logo image of TMD.CA

TITAN MEDICAL INC (TMD.CA) Stock Fundamental Analysis

Canada - TSX:TMD - CA88830X8199 - Common Stock

0.8 CAD
-0.04 (-4.76%)
Last: 11/22/2024, 7:00:00 PM
Fundamental Rating

2

Taking everything into account, TMD scores 2 out of 10 in our fundamental rating. TMD was compared to 16 industry peers in the Health Care Equipment & Supplies industry. TMD scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. TMD is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year TMD has reported negative net income.
TMD had a negative operating cash flow in the past year.
TMD had negative earnings in 4 of the past 5 years.
TMD had negative operating cash flow in 4 of the past 5 years.
TMD.CA Yearly Net Income VS EBIT VS OCF VS FCFTMD.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -20M -40M

1.2 Ratios

Looking at the Return On Assets, with a value of -111.81%, TMD is doing worse than 75.00% of the companies in the same industry.
With a Return On Equity value of -184.94%, TMD perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
ROA -111.81%
ROE -184.94%
ROIC N/A
ROA(3y)-183.23%
ROA(5y)-374.13%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TMD.CA Yearly ROA, ROE, ROICTMD.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5K 10K

1.3 Margins

In the last couple of years the Operating Margin of TMD has grown nicely.
TMD does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3Y34.2%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TMD.CA Yearly Profit, Operating, Gross MarginsTMD.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 -100 -150

More info and screens

5

2. Health

2.1 Basic Checks

TMD does not have a ROIC to compare to the WACC, probably because it is not profitable.
TMD has more shares outstanding than it did 1 year ago.
TMD has more shares outstanding than it did 5 years ago.
The debt/assets ratio for TMD has been reduced compared to a year ago.
TMD.CA Yearly Shares OutstandingTMD.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
TMD.CA Yearly Total Debt VS Total AssetsTMD.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

2.2 Solvency

Based on the Altman-Z score of -81.60, we must say that TMD is in the distress zone and has some risk of bankruptcy.
TMD's Altman-Z score of -81.60 is on the low side compared to the rest of the industry. TMD is outperformed by 81.25% of its industry peers.
TMD has a Debt/Equity ratio of 0.22. This is a healthy value indicating a solid balance between debt and equity.
TMD has a Debt to Equity ratio of 0.22. This is in the better half of the industry: TMD outperforms 68.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Altman-Z -81.6
ROIC/WACCN/A
WACC7.75%
TMD.CA Yearly LT Debt VS Equity VS FCFTMD.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M -40M

2.3 Liquidity

TMD has a Current Ratio of 3.73. This indicates that TMD is financially healthy and has no problem in meeting its short term obligations.
TMD has a Current ratio of 3.73. This is amongst the best in the industry. TMD outperforms 81.25% of its industry peers.
TMD has a Quick Ratio of 3.73. This indicates that TMD is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of TMD (3.73) is better than 81.25% of its industry peers.
Industry RankSector Rank
Current Ratio 3.73
Quick Ratio 3.73
TMD.CA Yearly Current Assets VS Current LiabilitesTMD.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

More info and screens

0

3. Growth

3.1 Past

TMD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 65.90%, which is quite impressive.
Looking at the last year, TMD shows a very negative growth in Revenue. The Revenue has decreased by -94.31% in the last year.
The Revenue has been decreasing by -4.11% on average over the past years.
EPS 1Y (TTM)65.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-109.99%
Revenue 1Y (TTM)-94.31%
Revenue growth 3Y-4.11%
Revenue growth 5YN/A
Sales Q2Q%-100%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
TMD.CA Yearly Revenue VS EstimatesTMD.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2023 5M 10M 15M 20M
TMD.CA Yearly EPS VS EstimatesTMD.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 -1 -2 -3 -4 -5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for TMD. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TMD.CA Price Earnings VS Forward Price EarningsTMD.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TMD.CA Per share dataTMD.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 -0.1 -0.15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

TMD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TITAN MEDICAL INC

TSX:TMD (11/22/2024, 7:00:00 PM)

0.8

-0.04 (-4.76%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)N/A N/A
Inst Owners0.46%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap35.40M
Revenue(TTM)950.00K
Net Income(TTM)-5047000
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 26.6
P/FCF N/A
P/OCF N/A
P/B 9.26
P/tB 9.26
EV/EBITDA N/A
EPS(TTM)-0.06
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.19
FCFYN/A
OCF(TTM)-0.18
OCFYN/A
SpS0.03
BVpS0.09
TBVpS0.09
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -111.81%
ROE -184.94%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-183.23%
ROA(5y)-374.13%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y34.2%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 96.67%
Cap/Sales 12.21%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.73
Quick Ratio 3.73
Altman-Z -81.6
F-Score1
WACC7.75%
ROIC/WACCN/A
Cap/Depr(3y)113.76%
Cap/Depr(5y)424.92%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)65.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-109.99%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-94.31%
Revenue growth 3Y-4.11%
Revenue growth 5YN/A
Sales Q2Q%-100%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y78.67%
EBIT growth 3Y28.68%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y83.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y83.06%
OCF growth 3YN/A
OCF growth 5YN/A

TITAN MEDICAL INC / TMD.CA FAQ

Can you provide the ChartMill fundamental rating for TITAN MEDICAL INC?

ChartMill assigns a fundamental rating of 2 / 10 to TMD.CA.


What is the valuation status for TMD stock?

ChartMill assigns a valuation rating of 0 / 10 to TITAN MEDICAL INC (TMD.CA). This can be considered as Overvalued.


What is the profitability of TMD stock?

TITAN MEDICAL INC (TMD.CA) has a profitability rating of 1 / 10.


Can you provide the financial health for TMD stock?

The financial health rating of TITAN MEDICAL INC (TMD.CA) is 5 / 10.